Cencora (0HF3.L) Q4 2024 Earnings Report

Previous: Q3 2024 Next: Q1 2025

Cencora

0HF3.L

$340.47 1.03%

Exchange: LSE | Sector: Healthcare | Industry: Medical Distribution

Q4 2024

Published: Nov 26, 2024

Earnings Highlights

Revenue of $79.05B up 14.7% year-over-year
EPS of $0.02 decreased by 98.9% from previous year
Gross margin of 3.2%
Net income of 3.38M
""While our operational costs have increased, we believe these investments will bolster our market position in the long-term."" - CFO

0HF3.L

Cencora

Period Q4 2024

Currency USD

Report Type Quarterly Earnings

Generated Dec 8, 2025

Executive Summary

In Q4 2024, Cencora (0HF3.L) reported significant year-over-year revenue growth of 14.69%, reaching $79.05 billion, largely driven by increased demand in its healthcare solutions segments. However, profit margins declined sharply, with net income plummeting by 99.04% to just $3.38 million. This considerable drop in profitability is attributed to rising operational costs and strategic investments that have yet to yield measurable outputs. Despite challenges in maintaining profitability, the company remains well positioned due to its extensive distribution network and a growing portfolio of essential healthcare products, particularly as demand from healthcare systems continues to grow.

Key Performance Indicators

Revenue

Increasing

79.05B

QoQ: 6.48% | YoY: 14.69%

Gross Profit

Increasing

2.49B

3.15% margin

QoQ: 19.45% | YoY: 10.60%

Operating Income

Decreasing

126.64M

QoQ: -82.00% | YoY: -73.45%

Net Income

Decreasing

3.38M

QoQ: -99.30% | YoY: -99.04%

EPS

Decreasing

0.02

QoQ: -99.18% | YoY: -98.85%

Revenue Trend

Margin Analysis

Financial Highlights

2024 Q4 Results:

- Revenue: $79.05 billion (+14.69% YoY, +6.48% QoQ)
- Gross Profit: $2.49 billion (+10.60% YoY, +19.45% QoQ)
- Operating Income: $126.64 million (-73.45% YoY, -82.00% QoQ)
- Net Income: $3.38 million (-99.04% YoY, -99.30% QoQ)
- EPS: $0.02 (-98.85% YoY, -99.18% QoQ)

The Company's gross profit margin remains thin at 3.14%, reflecting ongoing pressure on pricing amid increased operational expenses. Cencoraâ€™s current ratio of 0.879 and long-term debt to capitalization ratio of 0.848 suggest caution in liquidity and capital expenditures, showing the need for careful cash management moving forward.

Income Statement

Metric	Value	YoY Change	QoQ Change
Revenue	79.05B	14.69%	6.48%
Gross Profit	2.49B	10.60%	19.45%
Operating Income	126.64M	-73.45%	-82.00%
Net Income	3.38M	-99.04%	-99.30%
EPS	0.02	-98.85%	-99.18%

Key Financial Ratios

Gross Profit Margin

Weak

2.80%

Gross profit margin is below industry norms, profitability concerns

Operating Profit Margin

Weak

0.92%

Operating margin is below industry norms, profitability concerns

Net Profit Margin

Weak

0.00%

Net profit margin is below industry norms, profitability concerns

Return on Assets

Weak

0.01%

Return on assets suggests inefficient capital allocation

Return on Equity

Weak

0.43%

Return on equity suggests inefficient capital allocation

Current Ratio

Concern

0.88

Current ratio below safe levels, potential liquidity risk

Debt to Equity

High Risk

5.58

Debt-to-equity indicates high leverage and elevated financial risk

P/E Ratio

High Growth

3,253.37x

Very high P/E indicates aggressive growth expectations, higher risk

Price to Book

High Premium

55.94x

Very high premium suggests asset-light business model or lofty expectations

Historical Earnings Comparison

Period	Revenue ($M)	EPS ($)	YoY Growth	Report
Q3 2025	80,663.53	3.52	+8.7%	View
Q2 2025	75,453.67	3.68	+10.3%	View
Q1 2025	81,487.06	2.50	+12.8%	View
Q4 2024	79,050.11	0.02	+14.7%	View
Q3 2024	74,241.35	2.42	+7.7%	View

Cencora (0HF3.L) Q4 2024 Earnings Report

Earnings Highlights

Executive Summary

Key Performance Indicators

Revenue Trend

Margin Analysis

Financial Highlights

Income Statement

Key Financial Ratios

Management Insights Available for Members

Peer Comparison Available for Members

Investment Outlook & SWOT Available for Members

Historical Earnings Comparison

More 0HF3.L Quarterly Reports

0HF3.L

0HF3.L

0HF3.L

0HF3.L

Related Financial Data

Sector Analysis: Healthcare

0HF3.L Full Profile

0HF3.L Financial Statements

Earnings Calendar